Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10005783 Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

Patent 10005783 was granted and assigned to Array Biopharma Inc. on June, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Array Biopharma Inc.

Current Assignee

Array Biopharma Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

June 26, 2018

Patent Application Number

15399389

Date Filed

January 5, 2017

Patent Citations Received

US Patent 11267818 Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

US Patent 10758542 Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors

US Patent 10774085 Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds

US Patent 11484535 Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a] pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide

US Patent 10590139 Method of treatment using substituted imidazo[1,2b]pyridazine compounds

US Patent 10724102 Point mutations in TRK inhibitor-resistant cancer and methods relating to the same

Patent Primary Examiner

Patent abstract

Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10005783 Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool